InDevR Raises $7 million in Series A Financing with Adjuvant Capital
Boulder, CO, 10 September 2019 – InDevR, Inc., a biotechnology [...]
ESACT 2017
InDevR was represented at the ESACT 2017 meeting, May 14-17 [...]
VaxArray Study Published in Vaccine
VaxArray Flu Vaccine Potency Study Published in Vaccine InDevR’s Study, [...]
BIO 2016
InDevR is exhibited in booth 5583 in the BioProcess Zone at the BIO [...]
Vaccines R&D-2015
Dr. Kathy Rowlen presented the latest data for VaxArray Influenza at the [...]
